Aclidinium/Formoterol Fixed Combination Dose Finding Study
NCT00626522
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
808
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG:
Aclidinium bromide and formoterol
DRUG:
Aclidinium bromide and formoterol placebo
Sponsor
AstraZeneca